全省妊娠期糖尿病筛查政策变化对治疗及新生儿出生体重的影响
该研究评估了加拿大不列颠哥伦比亚省2010年妊娠期糖尿病筛查推荐从两步法改为一步法与两步法混合后对治疗及新生儿出生体重的影响。采用中断时间序列分析纳入2004至2019年463881例单胎妊娠,结果显示生活方式治疗的妊娠期糖尿病立即增加1.85%,但药物治疗的妊娠期糖尿病、新生儿出生体重结局及内分泌科就诊无变化。
要点
- 筛查政策改变后,生活方式治疗的妊娠期糖尿病发生率立即增加1.85%。
- 药物治疗的妊娠期糖尿病在短期(3年)政策后期间无变化。
- 新生儿大于胎龄儿、小于胎龄儿及内分泌科就诊均无变化。
核心结论
- 改变筛查方法大幅增加了生活方式治疗的妊娠期糖尿病诊断,但未影响药物治疗的妊娠期糖尿病或新生儿出生体重。
研究设计与样本
- 中断时间序列分析,纳入加拿大不列颠哥伦比亚省2004至2019年所有463881例单胎妊娠(>28孕周)个体。
主要发现
- 筛查改变后,生活方式治疗的妊娠期糖尿病立即增加(水平变化1.85 [95% CI 1.19-2.51]),相当于发生率增加1.85%。
- 药物治疗的妊娠期糖尿病逐渐增加(趋势变化每年0.23 [95% CI 0.09-0.37]),但在较短(3年)政策后期间无变化(水平变化-0.31 [95% CI -0.9 to 0.29];趋势变化0.03 [95% CI -0.36 to 0.43])。
- 未检测到新生儿出生体重结局和内分泌科就诊的变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate changes in gestational diabetes mellitus (GDM) treatment and newborn birth weight after a 2010 change in GDM screening recommendations from a two-step (50-g glucose challenge test + 3-h, 100-g oral glucose tolerance test [OGTT] with Carpenter-Coustan criteria) to a mix of one-step and two-step (2-h, 75-g OGTT with International Association for Diabetes in Pregnancy Study Group criteria). RESEARCH DESIGN AND METHODS: We estimated effects of the screening change on the incidence of lifestyle or medication treatment, infant birth weight >90th percentile or <10th percentile for gestational age (large and small for gestational age), and endocrinologist visits using interrupted time series analysis in all 463,881 individuals with singleton pregnancies (>28 gestational weeks) from British Columbia, Canada, between 2004 and 2019. RESULTS: After the screening change, lifestyle-treated GDM increased immediately (level change 1.85 [95% CI 1.19-2.51]), corresponding to a 1.85% increase in incidence. Medication-treated GDM increased gradually (trend change 0.23 [95% CI 0.09-0.37] per year), but there was no change in medication-treated GDM using a shorter (3-year) postpolicy period (level change -0.31 [95% CI -0.9 to 0.29]; trend change 0.03 [95% CI -0.36 to 0.43]). We detected no change in infant birth weight outcomes and endocrinology visits. CONCLUSIONS: Changing the screening approach substantially increased diagnoses of lifestyle-treated GDM but did not impact medication-treated GDM or infant birth weight.
引用
- Nethery E, Hutcheon JA, Lee J, et al. Effects of a Province-Wide Change in Gestational Diabetes Mellitus Screening Policy on Treatment and Newborn Birth Weight. Diabetes Care. 2025. PMID: 40465469. doi:10.2337/dc25-0480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。